XBI
- SPDR S&P Biotech ETFInformación clave
| Fecha más antigua | 2006-02-06 |
Información del ETF
| Proveedor del fondo | State Street |
| Índice | S&P Biotechnology Select Industry |
| Ratio de gastos | 0.35% |
| Número de posiciones | 140 |
| Fecha de lanzamiento | 2006-01-31 |
| Clase de activo | Equity |
| Cotización | US-listed |
| Sector | Healthcare |
| Estilo de inversión | Growth |
| Sin apalancamiento | Non-leveraged |
Acerca de XBI
The SPDR S&P Biotech ETF (XBI) provides exposure to the biotechnology sector in the United States, offering a diversified portfolio of mid-cap and small-cap securities. The fund tracks the S&P Biotechnology Select Industry Index, using an equal-weighted methodology to balance assets across all components. This ETF is suitable for investors seeking to fine-tune their exposure to the health care sector or those bullish on biotechnology over the long run.